Cargando…
A framework and road map for rapid start-up and completion of a COVID-19 vaccine trial: A single clinical trial site experience
The COVID-19 global pandemic required the rapid development of vaccines with a quick start up of phase 1–3 studies with large enrollment targets. The University of California San Diego was identified as a site for the phase 3 trial of the mRNA-1273-SARS-CoV-2 vaccine. There were many challenges with...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cambridge University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889226/ https://www.ncbi.nlm.nih.gov/pubmed/35291217 http://dx.doi.org/10.1017/cts.2022.3 |